Larry Allen, MD, MHS, and Kenneth B Margulies, MD, discuss HF management for American Heart Month and Heart Failure Awareness Week. Advances in heart failure research and management have led to ...

For patients hospitalized with acute decompensated heart failure (ADHF), the eLym System from Ireland-based WhiteSwell has the potential to reduce the likelihood of rehospitalization and/or mortality ...

John C. Burnett Jr is in the Department of Cardiovascular Medicine and the Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, USA. Dunn and co-workers ...

Study: Engineered heart muscle allografts for heart repair in primates and humans. Image Credit: mi_viri/Shutterstock.com In a study published in Nature, researchers found that a stem cell-derived ...

For people with advanced heart failure, left ventricular assist devices, or LVADs, can be a literal lifesaver. The implantable devices, which improve blood flow throughout the body, are often the last ...

Credit: Getty Images A 65-year-old woman presents to her primary care provider with a chief complaint of "feeling winded" for the last 3 weeks. A 65-year-old woman presents to her primary care ...

Current models of mortality risk after heart failure (HF) rely primarily on cardiac-specific clinical variables and may underestimate risk in elderly East Asian patients. Researchers from Japan used ...

Finerenone is now approved for heart failure with LVEF ≥40%, expanding treatment options for this growing patient group with poor prognosis. The FINEARTS-HF trial showed finerenone significantly ...

The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...

In the U.S. alone, more than 6.7 million people have heart failure, a number that is projected to increase to more than 8.5 million by 2030. Heart failure is a progressive condition in which the heart ...